Moreover, several studies have demonstrated that high FOXM1 expression is associated with poor prognosis of patients with cancer having various tumors, including colorectal cancer [22], pancreatic ductal adenocarcinoma [42], hepatocellular carcinoma [43], non-small cell lung cancer [43], ovarian cancer [44], and GC [25]. This evidence concerns the gene FOXM1 and gastric cancer.